-

Wiley and FinELib Sign Transitional Agreement Continuing Expansion in Open Access

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc. (NYSE: JWA) (NYSE: JWB), a global leader in research and education, and FinELib, a Finnish consortium of higher education and research institutions, have announced a new three-year license that combines an open access and subscription agreement effective February 2020. This 3-year agreement will provide 22 Finnish institutions with continued access to Wiley’s subscription journals and enables their affiliated authors to publish open access articles in Wiley’s fully gold and hybrid journals.

“FinELib is pleased to announce an agreement with Wiley offering open access publishing options for our researchers. With this agreement the amount of open access articles will increase substantially,” stated Arja Tuuliniemi, head of licensing at FinELib.

“We are very pleased to partner with FinELib to advance the open access landscape in Finland. This is an exciting continuation down the path to an open research future,” said Judy Verses, Wiley’s executive vice president, Research.

As part of the agreement, eligible researchers and students will be automatically identified and notified of the opportunity to publish open access through their institutional connection, at no additional charge. FinELib institutions will continue to have access to all of Wiley’s journal content. The 22 eligible institutions will also have access to a distinct open access account dashboard for easy administration of their account, quick article approval, and reporting.

Additional Information

About FinELib

FinELib is a consortium of Finnish higher education institutions, research institutions and public libraries. Its mission is to secure and improve the availability of electronic resources. FinELib promotes openness by negotiating transformative agreements in order to make a transition to open access, without additional costs for the scholarly community. More information at: http://finelib.fi/negotiations/.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Contacts

Wiley:
Brian Campbell (US): +1 201-748-6874
Investor Relations
Brian.campbell@wiley.com

Dawn Peters (US): +1 781-388-8408
Corporate Communications & Global Media Relations
newsroom@wiley.com
Follow us on Twitter @WileyNews

FinELib:
Arja Tuuliniemi: +358505706584
Head of Licensing, FinELib
arja.tuuliniemi@helsinki.fi

Toni Vesterinen: +358503183421
Licensing Coordinator, FinELib
toni.vesterinen@helsinki.fi
Twitter: @FinELibpalvelu

John Wiley & Sons, Inc.

NYSE:WLY
Details
Headquarters: Hoboken, New Jersey
CEO: Matthew Kissner
Employees: 7,000
Organization: PUB

Release Versions

Contacts

Wiley:
Brian Campbell (US): +1 201-748-6874
Investor Relations
Brian.campbell@wiley.com

Dawn Peters (US): +1 781-388-8408
Corporate Communications & Global Media Relations
newsroom@wiley.com
Follow us on Twitter @WileyNews

FinELib:
Arja Tuuliniemi: +358505706584
Head of Licensing, FinELib
arja.tuuliniemi@helsinki.fi

Toni Vesterinen: +358503183421
Licensing Coordinator, FinELib
toni.vesterinen@helsinki.fi
Twitter: @FinELibpalvelu

More News From John Wiley & Sons, Inc.

Wiley Names Jessica Kowalski Executive Vice President and General Manager, Research

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the appointment of Jessica Kowalski as Executive Vice President and General Manager, Research, effective May 11, 2026. She succeeds Jay Flynn, who shaped Wiley’s Research business during his tenure and is leaving the company. Kowalski joins Wiley from Microsoft, bringing more than two decades of experience leading knowledge, data, research publishing, and AI-ena...

Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wil...

Wiley to Expand Prestigious Advanced Journals Portfolio

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley to significantly expand the Advanced Portfolio into life, health, and social sciences disciplines, launching eight new journals in 2026....
Back to Newsroom